Medicare Enrolled

Dr. Alan Maloon, M.D.

Neuromusculoskeletal Medicine & OMM Physician · Roswell, GA
Speaking/Promotional
11650 ALPHARETTA HWY, Roswell, GA 30076
4703658855
In practice since 2006 (19 years)
NPI: 1093808057 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maloon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maloon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maloon

Dr. Alan Maloon is a neuromusculoskeletal medicine & omm physician in Roswell, GA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Maloon received a total of $99,391 from 52 pharmaceutical and/or device companies across 568 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neuromusculoskeletal medicine & omm physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maloon is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $99,391 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$99,391
Total received (2018-2024)
Avg $14,199/year across 7 years
Top 8% in GA for neuromusculoskeletal medicine & omm physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
568
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,251 (90.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,826 (4.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,314 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$34
2023
$218
2022
$16,158
2021
$24,410
2020
$31,454
2019
$1,290
2018
$25,827

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$17
Boston Scientific Corporation
$16
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$25,215
Allergan, Inc.
$20,355
Supernus Pharmaceuticals, Inc.
$18,300
AbbVie Inc.
$12,715
ABBVIE INC.
$8,179
Promius Pharma LLC
$4,826
Biohaven Pharmaceuticals, Inc.
$2,577
Egalet US Inc
$1,710
Allergan Inc.
$1,453
Teva Pharmaceuticals USA, Inc.
$581
UCB, Inc.
$428
Amgen Inc.
$347
Sunovion Pharmaceuticals Inc.
$314
IMPEL PHARMACEUTICALS INC.
$310
Biogen, Inc.
$215
Zyla Life Sciences, Inc.
$205
Biohaven Pharmaceutical Holding Company Ltd.
$175
Neurelis, Inc.
$145
Lundbeck LLC
$121
Upsher-Smith Laboratories LLC
$110
Harmony Biosciences LLC
$107
EMD Serono, Inc.
$94
SK Life Science, Inc.
$82
UPSHER-SMITH LABORATORIES LLC
$81
Novartis Pharmaceuticals Corporation
$76
Currax Pharmaceuticals LLC
$58
Avanir Pharmaceuticals, Inc.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
Almatica Pharma LLC
$44
GE Healthcare
$34
Mallinckrodt LLC
$33
Merz Pharmaceuticals, LLC
$33
PFIZER INC.
$31
Horizon Therapeutics plc
$29
Neurocrine Biosciences, Inc.
$28
Zyla Life Sciences
$26
Alexion Pharmaceuticals, Inc.
$25
Adamas Pharmaceuticals, Inc.
$23
Merz North America, Inc.
$23
GE HEALTHCARE
$18
W. L. Gore & Associates, Inc.
$18
ASSERTIO THERAPEUTICS, Inc.
$17
Collegium Pharmaceutical, Inc.
$16
Boston Scientific Corporation
$16
Kyowa Kirin, Inc.
$14
Aprecia Pharmaceuticals, LLC
$14
Vertical Pharmaceuticals, LLC
$14
Amneal Pharmaceuticals LLC
$13
ARBOR PHARMACEUTICALS, INC.
$13
Assertio Therapeutics, Inc.
$13
Medtronic USA, Inc.
$12
BANNER LIFE SCIENCES, LLC
$12
Top 3 companies account for 64.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · APTIOM · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Briviact · COPAXONE · Cambia · ELYXYB - celecoxib · EMGALITY · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Horizant · INGREZZA · KYNMOBI · Mavenclad · NAMZARIC · NAPRELAN · NOURIANZ · NURTEC ODT · Neupro · Nuedexta · ONZETRA XSAIL · OXTELLAR XR · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELEXXII · RESTORE · REYVOW · RYTARY · SOLIRIS · SPRIX · Spritam · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · Vimpat · Wakix · XEOMIN · Xeomin · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neuromusculoskeletal medicine & omm physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for neuromusculoskeletal medicine & omm physician in GA.

Looking for a neuromusculoskeletal medicine & omm physician in Roswell?
Compare neuromusculoskeletal medicine & omm physicians in the Roswell area by procedure volume, costs, and industry payment transparency.
Browse neuromusculoskeletal medicine & omm physicians nearby

Geographic Context

Neuromusculoskeletal medicine & omm physicians within 10 mi
21
Per 100K population
2.0
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Maloon is a neuromusculoskeletal medicine & omm physician, with speaking/promotional industry engagement in the top 8% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Maloon receive payments from pharmaceutical companies?
Yes. Dr. Maloon received a total of $99,391 from 52 companies across 568 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Maloon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →